Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00045630 · OUTCOME

Overall Survival (OS)

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium · Source last updated 2013-05-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
0-2 years

What was measured

Overall survival is defined from the date of registration to date of death from any cause

Analysis population: All eligible patients who started treatment were included in the analysis

Groups in this outcome

Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery

Patients receive 3 cycles (1 cycle = 21 days) of neoadjuvant chemotherapy (800 mg/m\^2 of gemcitabine IV and 80 mg/m\^2 of Paclitaxel IV on days 1 and 8 and Carboplatin IV on day 1), TURBT within 4-8 weeks of chemotherapy, option of proceeding with immediate cystectomy or observation.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery74

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery59Not reported4572Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        45
        upper Limit
        72
        value
        59
denoms
  1. counts
    1. group Id
      OG000
      value
      74
    units
    Participants
description
Overall survival is defined from the date of registration to date of death from any cause
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients receive 3 cycles (1 cycle = 21 days) of neoadjuvant chemotherapy (800 mg/m\^2 of gemcitabine IV and 80 mg/m\^2 of Paclitaxel IV on days 1 and 8 and Carboplatin IV on day 1), TURBT within 4-8 weeks of chemotherapy, option of proceeding with immediate cystectomy or observation.
    id
    OG000
    title
    Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery
param Type
NUMBER
population Description
All eligible patients who started treatment were included in the analysis
reporting Status
POSTED
time Frame
0-2 years
title
Overall Survival (OS)
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice